Cosentini, Deborah
 Distribuzione geografica
Continente #
NA - Nord America 1.838
EU - Europa 1.166
AS - Asia 388
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.402
Nazione #
US - Stati Uniti d'America 1.827
PL - Polonia 313
IT - Italia 263
CN - Cina 140
DE - Germania 135
FI - Finlandia 119
HK - Hong Kong 109
UA - Ucraina 86
IE - Irlanda 76
SG - Singapore 62
CZ - Repubblica Ceca 40
GB - Regno Unito 37
SE - Svezia 29
VN - Vietnam 28
IN - India 25
BE - Belgio 23
FR - Francia 21
JP - Giappone 15
CA - Canada 10
CH - Svizzera 8
NL - Olanda 6
RU - Federazione Russa 5
AZ - Azerbaigian 2
CL - Cile 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
ES - Italia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 3.402
Città #
Warsaw 313
Fairfield 275
Ashburn 191
Chandler 157
Seattle 119
Helsinki 112
Woodbridge 111
Hong Kong 108
Houston 105
New York 96
Wilmington 79
Cambridge 78
Jacksonville 76
Princeton 69
Ann Arbor 43
Boardman 42
Brescia 42
Dublin 42
Beijing 40
Singapore 36
Brno 34
Shanghai 33
Munich 32
West Jordan 30
Dong Ket 28
Los Angeles 27
Dalmine 24
Brussels 23
Menlo Park 22
Milan 21
Dearborn 20
Romola 20
Nanjing 16
Naples 16
Rome 13
San Diego 13
Pune 12
Washington 11
Des Moines 10
Gumyojicho 9
London 9
Turin 9
Nanchang 8
Lappeenranta 7
Mumbai 7
Changsha 6
Fukuoka 6
Jinan 6
Olomouc 6
Chicago 5
Dietikon 5
Perugia 5
San Francisco 5
Shenyang 5
Tianjin 5
Hebei 4
Leipzig 4
Livorno 4
Phoenix 4
Redwood City 4
Barberino di Mugello 3
Gardone Val Trompia 3
Genoa 3
Guangzhou 3
North York 3
Norwalk 3
Rockville 3
Toronto 3
Augusta 2
Bergamo 2
Berlin 2
Borås 2
Brooklyn 2
Chiswick 2
Cornuda 2
Falkenstein 2
Fuzhou 2
Gradara 2
Gunzenhausen 2
Hounslow 2
Huizen 2
Leawood 2
Lisbon 2
Melfi 2
New Bedfont 2
Ottawa 2
Parma 2
Pianello del Lario 2
Poli 2
Quarrata 2
Rochester 2
S. Pietro 2
Salò 2
San Felice A Cancello 2
San Giuliano Milanese 2
Taichung 2
Taizhou 2
Würzburg 2
Zhengzhou 2
Acton 1
Totale 2.749
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 180
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 169
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 165
Immunotherapy failure in adrenocortical cancer: where next? 157
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 145
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 143
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 142
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 124
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 118
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 115
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 107
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 100
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 100
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 99
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 93
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 88
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 79
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 76
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 64
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 60
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 51
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 51
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 48
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 47
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 46
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 44
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 43
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 40
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 39
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 38
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 37
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 35
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 35
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 32
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 30
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 30
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 29
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 28
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 27
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 27
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 27
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 26
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 24
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 22
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 22
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 21
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 21
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 21
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 21
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 20
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 19
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 18
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 18
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 16
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 15
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 13
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 13
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 13
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 9
null 8
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 8
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 10.1007/s40618-023-02174-5) 8
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 7
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 7
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review 7
The Evolving Treatment Landscape of Medullary Thyroid Cancer 4
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 4
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 4
Totale 3.497
Categoria #
all - tutte 23.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020614 0 0 21 63 53 82 75 79 66 70 47 58
2020/2021768 35 88 72 91 67 74 32 68 48 88 38 67
2021/2022398 37 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024930 43 32 75 75 74 171 27 50 133 61 25 164
2024/2025131 56 46 29 0 0 0 0 0 0 0 0 0
Totale 3.497